|
| |
ADVANCED PROGRAM
| THURSDAY, FEBRUARY
10, 2000 |
| 10:00-12:30 |
 |
General Ocular Pharmacology:
MANAGING GLAUCOMA IN THE YEAR 2000 AND BEYOND
Sponsored by: MERCK
Chairperson: V.P. Costa, Sao Paulo SP, Brazil |
HALL A
|
| 13:50-14:00 |
 |
Opening Ceremony: |
HALL A |
| 14:00-15:00 |
 |
ACADEMIA
INDUSTRY COLLABORATION IN DRUG DEVELOPMENT
Chairperson: R. Neumann, Tel Aviv, Israel |
HALL A |
| 15:00-17:00 |
 |
CLINICAL STUDIES
Chairpersons: R. David, Irvine CA, USA
C.A. Paterson, Louisville KY, USA |
HALL A |
| 16:30-17:00 |
 |
COMMUNICATING
RESEARCH DATA |
HALL A |
| 17:00-17:45 |
 |
THE REGULATORY
FACET OF DRUG DEVELOPMENT:
ICH - A SYSTEM IN DEVELOPMENT
Chairperson: W.A. Chambers, Rockville MD, USA |
HALL A |
| 18:00-19:00 |
 |
Roundtable
Discussion:
PRESERVING THE FREE SPIRIT OF INNOVATION IN A REGULATED WORLD
Moderator: J.P. Nordmann, Paris, France |
HALL A |
| FRIDAY, FEBRUARY
11, 2000 |
| 08:00-09:15 |
 |
ANTIOXIDANTS
Chairpersons: T. Hiramitsu, Hamamatsu, Japan
M. Meydani, Boston MA, USA |
HALL A |
| 09:15-10:10 |
 |
HERBAL MEDICINE
Chairpersons: F. Drago, Catania, Italy
D. Balasubramanian, Hyderabad, India |
HALL A |
| 10:10-11:30 |
 |
HERBAL MEDICINE
FOR INFLAMMATORY EYE DISEASES
Session Organizer: C.S. Foster, Boston MA, USA |
HALL A |
| 11:30-12:15 |
 |
Company Product
Session:
NEW DRUGS BY SENJU
Sponsored by: SENJU PHARMACEUTICALS CO. Ltd |
HALL A |
| 12:15-13:30 |
 |
UVEITIS &
INFLAMMATION I
Chairpersons: M.D. De Smet, Amsterdam, The Netherlands
M. Zierhut, Tubingen, Germany |
HALL A |
| 14:30-15:25 |
 |
UVEITIS &
INFLAMMATION II
Chairpersons: S.R. Thurau, Munich, Germany
R. Proenca, Coimbra, Portugal |
HALL A |
| 15:25-16:10 |
 |
Company
Sponsored Session:
LOTEPREDNOL ETABONATE (LOTEMAX)
Sponsored by: BAUSCH & LOMB Pharmaceuticals
Chairperson: R. Neumann, Tel Aviv, Israel |
HALL A |
| 16:10-18:00 |
 |
APOPTOSIS:
FRONTIERS OF DRUG DISCOVERY
Chairperson: N. Agarwal, Fort Worth Texas, USA |
HALL A |
| 08:00-10:45 |
 |
OCULAR SURFACE
DISEASES
Chairpersons: P.A. Asbell, New York NY, USA
M.A. Lemp, Washington DC, USA |
HALL
B |
| 10:45-11:30 |
 |
Company
Sponsored Session:
OCULAR SURFACE DISEASES:
Sponsored by: ALLERGAN, Inc.
Chairperson: C. Baudouin, Bologne, France |
HALL
B |
| 11:30-12:45 |
 |
BLOOD
FLOW (RETINAL ASPECTS)
Chairpersons: A. Harris, Indianapolis IN, USA
S.E. Bursell, Boston MA, USA
A.R. Figueiredo, Lisbon, Portugal |
HALL
B |
| 12:45-13:30 |
 |
Company
Sponsored Session:
CO-REGULATION: CHANGING THE WAY GLAUCOMA IS MANAGED
Sponsored by: MERCK & Co., Inc.
Chairperson: V.P. Costa, Sao Paulo SP, Brazil |
HALL
B |
| 14:30-15:15 |
 |
Company
Sponsored Session:
A NOVEL APPROACH TO THE MANAGEMENT OF GLAUCOMA: THE DOCOSANOID DERIVATIVE UNOPROSTONE
ISOPROPYL
Sponsored by: CIBA VISION
Chairperson: V. Sanz, Spain |
HALL
B |
| 15:15-17:40 |
 |
IMAGING
Chairpersons: S. Krupsky, Tel Hashomer, Israel
J.S. Schuman, Boston MA, USA |
HALL B |
| SATURDAY, FEBRUARY 12, 2000 |
| 08:00-10:30 |
 |
DRUG
DELIVERY
Chairpersons: R. Gurny, Geneva, Switzerland
P. Ashton, Watertown MA, USA |
HALL A |
| 10:30-12:00 |
 |
PHOTODYNAMIC
THERAPY FOR MACULAR DEGENERATION
Chairperson: J.W. Miller, Boston MA, USA |
HALL A |
| 12:00-12:45 |
 |
Company
Sponsored Session:
PHOTODYNAMIC THERAPY
Sponsored by: Ciba Vision
Chairperson: E.S. Gragoudas, Boston MA, USA |
HALL A |
| 12:45-13:30 |
 |
Company
Sponsored Session:
0.5% LEVOFLOXACIN OPHTHALMIC SOLUTION
Sponsored by: SANTEN
Chairperson: T.P. O'Brien, Baltimore MD, USA |
HALL A |
| 14:30-16:25 |
 |
ANTIMICROBIAL
THERAPY
Chairperson: T.P. O'brien, Baltimore MD, USA |
HALL A |
| 16:25-17:55 |
 |
LOCAL
CHEMOTHERAPY IN THE TREATMENT OF OCULAR MALIGNANCIES
Chairperson: J. Pe'er, Jerusalem, Israel |
HALL A |
| 08:00-09:45 |
 |
GLAUCOMA
Session Organizer: W. Stewart, USA
Chairpersons: S. Melamed, Tel Hashomer, Israel
P. Kaufman, Madison WI, USA
W.C. Stewart, Charleston SC, USA |
HALL B |
| 09:45-10:30 |
 |
Company
Sponsored Session:
MEDICAL TREATMENT MODALITIES FOR GLAUCOMA
Sponsored by: ALLERGAN, Inc.
Chairperson: S.A. Gandolfi, Parma, Italy |
HALL B |
| 10:30-11:15 |
 |
DISCUSSION
GROUP I:
CURRENT AND FUTURE USEFULNESS OF BLOOD FLOW PARAMETERS IN THE MANAGEMENT
OF GLAUCOMA
Moderator: J.P. Nordmann, Paris, France |
HALL B |
| 11:15-12:35 |
 |
GENETICS IN
OPHTHALMOLOGY
Session Organizer: E.C. Si, Alameda CA, USA |
HALL B |
| 12:50-13:30 |
 |
DISCUSSION GROUP II:
CURRENT AND FUTURE USES OF GENETIC THERAPY IN GLAUCOMA MANAGEMENT
Moderator: N. Pfeiffer, Mainz, Germany |
HALL B |
| 14:30-16:15 |
 |
OCULAR
NEUROPROTECTION
Session Organizer: L.A. Levin, Madison WI, USA |
HALL B |
| 16:15-17:25 |
 |
THE
NEUROPROTECTION FACET OF GLAUCOMA THERAPY
Chairperson: D.A. Lee, Los Angeles CA, USA |
HALL B |
| 17:35-18:15 |
 |
GLAUCOMA DISCUSSION GROUP III:
SUGGESTED STEPWISE THERAPY FOR GLAUCOMA AND OCULAR HYPERTENSION: MEDICAL
AND SURGICAL
Moderator: T.J. Zimmerman, Louisville KY, USA |
HALL B |
| SUNDAY, FEBRUARY 13, 2000 |
| 08:00-10:30 |
 |
RETINA
Chairpersons: A. Kampik, Munich, Germany
J.G. Cunha-Vaz, Coimbra, Portugal
C. Correia, Oporto, Portugal |
HALL A |
| 10:30-12:15 |
 |
ANTI-ANGIOGENESIS
Chairpersons: D. Armstrong, Buffalo, NY, USA
R.J. D'amato, Boston MA, USA |
HALL A |
| 13:30-15:30 |
 |
OCULAR
TOXICOLOGY
Chairperson: J.D. Bartlett, Birmingham AL, USA |
HALL A |
| 08:00-09:05 |
 |
BLOOD FLOW
(OPTIC NERVE)
Chairpersons: A. Harris, Indianapolis IN, USA
L.E. Pillunat, Hamburg, Germany
O. Geyer, Tel Aviv, Israel |
HALL B |
| 09:05-10:05 |
 |
OCULAR
ALLERGY
Chairpersons: M.B. Abelson, North Andover MA, USA
S. Bonini, Rome, Italy |
HALL B |
| 10:05-10:50 |
 |
NOVEL
OCULAR ANTIHISTAMINE "EMADINE"
Sponsored by: ALCON Laboratories
Chairperson: M.B. Abelson, North Andover MA, USA |
HALL B |
| 10:50-12:30 |
 |
SURGICAL
PHARMACOLOGY
Chairpersons: J.C. Pastor- Jimeno, Valladolid, Spain
P. Abrantes, Portugal |
HALL B |
| 13:30-16:00 |
 |
GLAUCOMA
Chairpersons: L. Metzner-Serra, Lisbon, Portugal
P.A. Netland, Memphis TN, USA
M. Araie, Tokyo, Japan |
HALL B |
|
 |
POSTER
SESSION |
EXHIBITION HALL |
|
